Everstone Capital Exits Burger King India, Ajanta Pharma Family Office to Invest ₹800 Crore

Everstone Capital exits Restaurant Brands Asia, selling its Burger King India stake as Ajanta Pharma family office plans a strategic ₹800 crore investment.

Jan 20, 2026 - 00:08
Jan 21, 2026 - 21:46
 0
Everstone Capital Exits Burger King India, Ajanta Pharma Family Office to Invest ₹800 Crore

Private equity firm Everstone Capital is set to make a full exit from Restaurant Brands Asia (RBA), marking the end of its decade-long association with Burger King in India. The stake is being acquired by the family office of the promoters of Ajanta Pharma, signalling a significant ownership and strategic shift at the quick-service restaurant (QSR) operator.

Everstone Capital to Sell Entire RBA Stake

Everstone Capital is selling its entire remaining 11.26% stake in Restaurant Brands Asia, which operates Burger King outlets in India and Indonesia. The transaction is expected to be executed through a block deal on January 20, 2026.

Based on prevailing market prices, the stake is valued at around ₹480 crore ($57 million). However, the overall transaction size could be significantly larger due to fresh capital being infused into the company.

Ajanta Pharma Family Office Emerges as Strategic Investor

The Agrawal family—promoters of Ajanta Pharma—will enter RBA through their family office as a long-term strategic investor. Market sources indicate that the family office is willing to commit up to ₹800 crore ($88 million), suggesting a combination of secondary stake purchase and primary capital infusion.

This move aligns with RBA’s stock exchange disclosure announcing a board meeting on January 20, 2026, to evaluate fundraising options, reinforcing expectations of new capital entering the business.

Why This Deal Matters for Restaurant Brands Asia

The entry of a domestic family office with patient capital could prove crucial for Restaurant Brands Asia as it pursues aggressive growth plans. The company has outlined ambitions to scale its India network to 700 Burger King outlets by December 2026, while strengthening operations in Indonesia.

Industry watchers believe the Ajanta Pharma family office may gradually raise its holding over time, potentially becoming a majority shareholder if other investors pare their stakes.

End of a Decade-Long Journey for Everstone

Everstone Capital played a foundational role in bringing Burger King to India in 2013, later guiding the business through a successful IPO in 2020 and expanding into Indonesia. Over the past two years, the private equity firm has steadily reduced its exposure, including a major stake sale in 2023.

The latest transaction formally concludes Everstone’s involvement in one of India’s most closely watched QSR stories.

Market Reaction and Competitive Landscape

Shares of Restaurant Brands Asia have shown positive momentum amid reports of a committed strategic investor. The development comes at a time when India’s food services sector is witnessing consolidation and renewed focus on balance sheet strength.

With fresh capital, RBA is expected to accelerate store expansion, enhance supply chains, and sharpen menu innovation as it competes with rivals such as Westlife Foodworld (McDonald’s India – West & South) and KFC operators under Devyani International and Sapphire Foods.

The exit of Everstone and entry of the Ajanta Pharma family office mark a turning point for Restaurant Brands Asia. If executed as expected, the transaction could provide both ownership stability and financial flexibility, positioning Burger King India for its next phase of growth in an increasingly competitive QSR market.

Frequently Asked Questions (FAQ)

1. Why is Everstone Capital exiting Restaurant Brands Asia?

Everstone has been gradually monetising its investment after more than a decade, following RBA’s IPO and business expansion. The sale completes its planned exit strategy.

2. Who is buying Everstone’s stake in Burger King India?

The stake is being acquired by the family office of Ajanta Pharma promoters, led by the Agrawal family.

3. What is the total value of the deal?

While Everstone’s stake is valued at around ₹480 crore, the total capital commitment could go up to ₹800 crore, including fresh funds for RBA.

4. Will Ajanta Pharma promoters take majority control of RBA?

Currently, they are entering as strategic investors. However, reports suggest they may increase their holding over time, potentially moving towards majority ownership.

5. How will this impact Burger King’s expansion in India?

The fresh capital is expected to support faster store expansion, operational improvements, and long-term growth across India and Indonesia.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
Team IFT At Indian Food Times, our passionate writers bring you the latest food trends, industry insights, and delightful stories. With a commitment to quality journalism, we ensure every article is engaging and informative. Stay tuned for more!